- ￥1700 - 4000
- GeneTex
- 美国
- GTX132496
- 2025年07月14日
- WB
- Rabbit
- Drosophila
企业认证
相关产品推荐更多 >
![GFP antibody [GT859]](https://img1.dxycdn.com/2022/0329/189/2905432823665020453-14.jpg!wh200)
![PSA antibody [MSVA-603R] HistoMAX](https://custom.dxycdn.com/trademd/upload/pic/2013/11/12/A1383891150.jpg!small.t.1)
![SARS-CoV M antibody [2H2C4]](https://img1.dxycdn.com/2022/0328/648/3479263806677500453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant protein encompassing a sequence within the C-terminus region of Drosophila GEF-H1. The exact sequence is proprietary.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Drosophila
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Drosophila
- 目录编号：
GTX132496
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Rabbit
- 应用范围：
WB
- 浓度：
1.87 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
GEF-H1
- 抗体英文名：
GEF-H1 antibody
- 抗体名：
GEF-H1 抗体
- 规格：
100 μl/25 μl
| 规格： | 100 μl | 产品价格： | ￥4000.0 |
|---|---|---|---|
| 规格： | 25 μl | 产品价格： | ￥1700.0 |
Each well was loaded one brain homogenate as indicated were separated by 4-20% SDS-PAGE, and the membrane was blotted with CG10188 antibody (GTX132496) diluted at 1:5000.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验佚名 人工合成的H 1 受体阻断药多具有乙基胺的共同结构， Ar 1 和Ar 2 可为苯环或杂环，X可为氮、氧或碳，并与主核相联。乙基胺与组胺的侧链相似，对H 1 受体有较大亲和力，但无内在活性，故能竞争性阻断之。 【药理
Mini-Antibody Affinity Chromatography of Lysozyme
Multiple noncovalent forces do play a role in the binding between a protein antigen and an antibody directed against that protein. An antigen is bound by the antigen binding site of an antibody that consists of three hypervariable segments
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
技术资料暂无技术资料 索取技术资料
